nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Fibrosis—Methotrexate—colon cancer	0.0148	0.0148	CcSEcCtD
Deferiprone—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.0139	0.0139	CcSEcCtD
Deferiprone—Nystagmus—Vincristine—colon cancer	0.0122	0.0122	CcSEcCtD
Deferiprone—Hepatomegaly—Irinotecan—colon cancer	0.012	0.012	CcSEcCtD
Deferiprone—Nystagmus—Fluorouracil—colon cancer	0.0114	0.0114	CcSEcCtD
Deferiprone—Gastric ulcer—Capecitabine—colon cancer	0.0098	0.0098	CcSEcCtD
Deferiprone—Blood bilirubin increased—Irinotecan—colon cancer	0.009	0.009	CcSEcCtD
Deferiprone—Gait disturbance—Vincristine—colon cancer	0.00895	0.00895	CcSEcCtD
Deferiprone—Nephropathy—Methotrexate—colon cancer	0.00891	0.00891	CcSEcCtD
Deferiprone—Gait disturbance—Irinotecan—colon cancer	0.00872	0.00872	CcSEcCtD
Deferiprone—Furuncle—Methotrexate—colon cancer	0.00865	0.00865	CcSEcCtD
Deferiprone—Pulmonary embolism—Irinotecan—colon cancer	0.00851	0.00851	CcSEcCtD
Deferiprone—Torsade de pointes—Capecitabine—colon cancer	0.00812	0.00812	CcSEcCtD
Deferiprone—Hepatomegaly—Capecitabine—colon cancer	0.00805	0.00805	CcSEcCtD
Deferiprone—Haemoptysis—Capecitabine—colon cancer	0.0077	0.0077	CcSEcCtD
Deferiprone—Sepsis—Irinotecan—colon cancer	0.00739	0.00739	CcSEcCtD
Deferiprone—Sepsis—Fluorouracil—colon cancer	0.00707	0.00707	CcSEcCtD
Deferiprone—Pain in extremity—Vincristine—colon cancer	0.00634	0.00634	CcSEcCtD
Deferiprone—Rectal haemorrhage—Capecitabine—colon cancer	0.00631	0.00631	CcSEcCtD
Deferiprone—Osteoarthritis—Irinotecan—colon cancer	0.00618	0.00618	CcSEcCtD
Deferiprone—Cardiac failure—Fluorouracil—colon cancer	0.00606	0.00606	CcSEcCtD
Deferiprone—Blood bilirubin increased—Capecitabine—colon cancer	0.00602	0.00602	CcSEcCtD
Deferiprone—Osteoarthritis—Fluorouracil—colon cancer	0.00592	0.00592	CcSEcCtD
Deferiprone—Dehydration—Vincristine—colon cancer	0.0059	0.0059	CcSEcCtD
Deferiprone—Gait disturbance—Capecitabine—colon cancer	0.00584	0.00584	CcSEcCtD
Deferiprone—Dehydration—Irinotecan—colon cancer	0.00575	0.00575	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00571	0.00571	CcSEcCtD
Deferiprone—Pulmonary embolism—Capecitabine—colon cancer	0.0057	0.0057	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00556	0.00556	CcSEcCtD
Deferiprone—Pancreatitis—Irinotecan—colon cancer	0.00524	0.00524	CcSEcCtD
Deferiprone—Pancytopenia—Vincristine—colon cancer	0.00521	0.00521	CcSEcCtD
Deferiprone—Neutropenia—Vincristine—colon cancer	0.00513	0.00513	CcSEcCtD
Deferiprone—Photosensitivity reaction—Vincristine—colon cancer	0.005	0.005	CcSEcCtD
Deferiprone—Neutropenia—Irinotecan—colon cancer	0.00499	0.00499	CcSEcCtD
Deferiprone—Sepsis—Capecitabine—colon cancer	0.00494	0.00494	CcSEcCtD
Deferiprone—Pneumonia—Vincristine—colon cancer	0.00492	0.00492	CcSEcCtD
Deferiprone—Pancytopenia—Fluorouracil—colon cancer	0.00486	0.00486	CcSEcCtD
Deferiprone—Pneumonia—Irinotecan—colon cancer	0.00479	0.00479	CcSEcCtD
Deferiprone—Photosensitivity reaction—Fluorouracil—colon cancer	0.00467	0.00467	CcSEcCtD
Deferiprone—Jaundice—Irinotecan—colon cancer	0.00464	0.00464	CcSEcCtD
Deferiprone—Pneumonia—Fluorouracil—colon cancer	0.00459	0.00459	CcSEcCtD
Deferiprone—Infestation NOS—Fluorouracil—colon cancer	0.00456	0.00456	CcSEcCtD
Deferiprone—Infestation—Fluorouracil—colon cancer	0.00456	0.00456	CcSEcCtD
Deferiprone—Increased appetite—Capecitabine—colon cancer	0.0044	0.0044	CcSEcCtD
Deferiprone—Atrial fibrillation—Capecitabine—colon cancer	0.00436	0.00436	CcSEcCtD
Deferiprone—Urinary tract disorder—Vincristine—colon cancer	0.00433	0.00433	CcSEcCtD
Deferiprone—Connective tissue disorder—Vincristine—colon cancer	0.00431	0.00431	CcSEcCtD
Deferiprone—Urethral disorder—Vincristine—colon cancer	0.0043	0.0043	CcSEcCtD
Deferiprone—Epistaxis—Fluorouracil—colon cancer	0.0043	0.0043	CcSEcCtD
Deferiprone—Agranulocytosis—Fluorouracil—colon cancer	0.00426	0.00426	CcSEcCtD
Deferiprone—Arthritis—Capecitabine—colon cancer	0.00425	0.00425	CcSEcCtD
Deferiprone—Pulmonary embolism—Methotrexate—colon cancer	0.00424	0.00424	CcSEcCtD
Deferiprone—Cardiac failure—Capecitabine—colon cancer	0.00424	0.00424	CcSEcCtD
Deferiprone—Connective tissue disorder—Irinotecan—colon cancer	0.0042	0.0042	CcSEcCtD
Deferiprone—Diplopia—Capecitabine—colon cancer	0.00414	0.00414	CcSEcCtD
Deferiprone—Osteoarthritis—Capecitabine—colon cancer	0.00414	0.00414	CcSEcCtD
Deferiprone—Pain in extremity—Capecitabine—colon cancer	0.00414	0.00414	CcSEcCtD
Deferiprone—Cardiac disorder—Vincristine—colon cancer	0.00407	0.00407	CcSEcCtD
Deferiprone—Pharyngitis—Fluorouracil—colon cancer	0.00406	0.00406	CcSEcCtD
Deferiprone—Angiopathy—Vincristine—colon cancer	0.00398	0.00398	CcSEcCtD
Deferiprone—Cardiac disorder—Irinotecan—colon cancer	0.00397	0.00397	CcSEcCtD
Deferiprone—Mediastinal disorder—Vincristine—colon cancer	0.00396	0.00396	CcSEcCtD
Deferiprone—Angiopathy—Irinotecan—colon cancer	0.00388	0.00388	CcSEcCtD
Deferiprone—Immune system disorder—Irinotecan—colon cancer	0.00386	0.00386	CcSEcCtD
Deferiprone—Mediastinal disorder—Irinotecan—colon cancer	0.00385	0.00385	CcSEcCtD
Deferiprone—Dehydration—Capecitabine—colon cancer	0.00385	0.00385	CcSEcCtD
Deferiprone—Mental disorder—Vincristine—colon cancer	0.00384	0.00384	CcSEcCtD
Deferiprone—Chills—Irinotecan—colon cancer	0.00383	0.00383	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00372	0.00372	CcSEcCtD
Deferiprone—Back pain—Vincristine—colon cancer	0.0037	0.0037	CcSEcCtD
Deferiprone—Sepsis—Methotrexate—colon cancer	0.00368	0.00368	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00365	0.00365	CcSEcCtD
Deferiprone—Back pain—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Deferiprone—Pancytopenia—Capecitabine—colon cancer	0.00339	0.00339	CcSEcCtD
Deferiprone—Neutropenia—Capecitabine—colon cancer	0.00334	0.00334	CcSEcCtD
Deferiprone—Convulsion—Vincristine—colon cancer	0.00331	0.00331	CcSEcCtD
Deferiprone—Hypertension—Vincristine—colon cancer	0.0033	0.0033	CcSEcCtD
Deferiprone—Photosensitivity reaction—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Deferiprone—Weight increased—Capecitabine—colon cancer	0.00325	0.00325	CcSEcCtD
Deferiprone—Hypertension—Irinotecan—colon cancer	0.00321	0.00321	CcSEcCtD
Deferiprone—Pneumonia—Capecitabine—colon cancer	0.00321	0.00321	CcSEcCtD
Deferiprone—Infestation NOS—Capecitabine—colon cancer	0.00319	0.00319	CcSEcCtD
Deferiprone—Infestation—Capecitabine—colon cancer	0.00319	0.00319	CcSEcCtD
Deferiprone—Discomfort—Irinotecan—colon cancer	0.00313	0.00313	CcSEcCtD
Deferiprone—Anaphylactic shock—Vincristine—colon cancer	0.00312	0.00312	CcSEcCtD
Deferiprone—Jaundice—Capecitabine—colon cancer	0.00311	0.00311	CcSEcCtD
Deferiprone—Infection—Vincristine—colon cancer	0.0031	0.0031	CcSEcCtD
Deferiprone—Convulsion—Fluorouracil—colon cancer	0.00309	0.00309	CcSEcCtD
Deferiprone—Osteoarthritis—Methotrexate—colon cancer	0.00308	0.00308	CcSEcCtD
Deferiprone—Nervous system disorder—Vincristine—colon cancer	0.00306	0.00306	CcSEcCtD
Deferiprone—Anaphylactic shock—Irinotecan—colon cancer	0.00304	0.00304	CcSEcCtD
Deferiprone—Infection—Irinotecan—colon cancer	0.00302	0.00302	CcSEcCtD
Deferiprone—Hyperhidrosis—Vincristine—colon cancer	0.00301	0.00301	CcSEcCtD
Deferiprone—Hepatobiliary disease—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Deferiprone—Epistaxis—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Deferiprone—Discomfort—Fluorouracil—colon cancer	0.003	0.003	CcSEcCtD
Deferiprone—Nervous system disorder—Irinotecan—colon cancer	0.00298	0.00298	CcSEcCtD
Deferiprone—Agranulocytosis—Capecitabine—colon cancer	0.00297	0.00297	CcSEcCtD
Deferiprone—Hyperhidrosis—Irinotecan—colon cancer	0.00294	0.00294	CcSEcCtD
Deferiprone—Hypotension—Vincristine—colon cancer	0.00291	0.00291	CcSEcCtD
Deferiprone—Anaphylactic shock—Fluorouracil—colon cancer	0.00291	0.00291	CcSEcCtD
Deferiprone—Infection—Fluorouracil—colon cancer	0.00289	0.00289	CcSEcCtD
Deferiprone—Hepatitis—Capecitabine—colon cancer	0.00286	0.00286	CcSEcCtD
Deferiprone—Nervous system disorder—Fluorouracil—colon cancer	0.00285	0.00285	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00284	0.00284	CcSEcCtD
Deferiprone—Pharyngitis—Capecitabine—colon cancer	0.00284	0.00284	CcSEcCtD
Deferiprone—Hypotension—Irinotecan—colon cancer	0.00284	0.00284	CcSEcCtD
Deferiprone—Urinary tract disorder—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Deferiprone—Oedema peripheral—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Deferiprone—Connective tissue disorder—Capecitabine—colon cancer	0.00281	0.00281	CcSEcCtD
Deferiprone—Urethral disorder—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Deferiprone—Hypotension—Fluorouracil—colon cancer	0.00272	0.00272	CcSEcCtD
Deferiprone—Decreased appetite—Vincristine—colon cancer	0.00271	0.00271	CcSEcCtD
Deferiprone—Somnolence—Irinotecan—colon cancer	0.0027	0.0027	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Vincristine—colon cancer	0.00269	0.00269	CcSEcCtD
Deferiprone—Fatigue—Vincristine—colon cancer	0.00269	0.00269	CcSEcCtD
Deferiprone—Eye disorder—Capecitabine—colon cancer	0.00267	0.00267	CcSEcCtD
Deferiprone—Dyspepsia—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Deferiprone—Pain—Vincristine—colon cancer	0.00267	0.00267	CcSEcCtD
Deferiprone—Cardiac disorder—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00265	0.00265	CcSEcCtD
Deferiprone—Decreased appetite—Irinotecan—colon cancer	0.00264	0.00264	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00262	0.00262	CcSEcCtD
Deferiprone—Fatigue—Irinotecan—colon cancer	0.00262	0.00262	CcSEcCtD
Deferiprone—Pancreatitis—Methotrexate—colon cancer	0.00261	0.00261	CcSEcCtD
Deferiprone—Pain—Irinotecan—colon cancer	0.0026	0.0026	CcSEcCtD
Deferiprone—Angiopathy—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Deferiprone—Somnolence—Fluorouracil—colon cancer	0.00259	0.00259	CcSEcCtD
Deferiprone—Immune system disorder—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Deferiprone—Mediastinal disorder—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Deferiprone—Chills—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Deferiprone—Dyspepsia—Fluorouracil—colon cancer	0.00256	0.00256	CcSEcCtD
Deferiprone—Gastrointestinal pain—Vincristine—colon cancer	0.00255	0.00255	CcSEcCtD
Deferiprone—Decreased appetite—Fluorouracil—colon cancer	0.00253	0.00253	CcSEcCtD
Deferiprone—Pancytopenia—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00251	0.00251	CcSEcCtD
Deferiprone—Mental disorder—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Deferiprone—Malnutrition—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Deferiprone—Neutropenia—Methotrexate—colon cancer	0.00249	0.00249	CcSEcCtD
Deferiprone—Pain—Fluorouracil—colon cancer	0.00249	0.00249	CcSEcCtD
Deferiprone—Gastrointestinal pain—Irinotecan—colon cancer	0.00248	0.00248	CcSEcCtD
Deferiprone—Abdominal pain—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Deferiprone—Body temperature increased—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Deferiprone—Photosensitivity reaction—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Deferiprone—Back pain—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Deferiprone—Abdominal pain—Irinotecan—colon cancer	0.0024	0.0024	CcSEcCtD
Deferiprone—Body temperature increased—Irinotecan—colon cancer	0.0024	0.0024	CcSEcCtD
Deferiprone—Pneumonia—Methotrexate—colon cancer	0.00239	0.00239	CcSEcCtD
Deferiprone—Infestation NOS—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Deferiprone—Infestation—Methotrexate—colon cancer	0.00237	0.00237	CcSEcCtD
Deferiprone—Urticaria—Fluorouracil—colon cancer	0.00231	0.00231	CcSEcCtD
Deferiprone—Body temperature increased—Fluorouracil—colon cancer	0.0023	0.0023	CcSEcCtD
Deferiprone—Hypersensitivity—Vincristine—colon cancer	0.0023	0.0023	CcSEcCtD
Deferiprone—Hepatobiliary disease—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Deferiprone—Epistaxis—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Deferiprone—Hypersensitivity—Irinotecan—colon cancer	0.00224	0.00224	CcSEcCtD
Deferiprone—Asthenia—Vincristine—colon cancer	0.00224	0.00224	CcSEcCtD
Deferiprone—Agranulocytosis—Methotrexate—colon cancer	0.00221	0.00221	CcSEcCtD
Deferiprone—Asthenia—Irinotecan—colon cancer	0.00218	0.00218	CcSEcCtD
Deferiprone—Hypertension—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Deferiprone—Hypersensitivity—Fluorouracil—colon cancer	0.00214	0.00214	CcSEcCtD
Deferiprone—Diarrhoea—Vincristine—colon cancer	0.00213	0.00213	CcSEcCtD
Deferiprone—Hepatitis—Methotrexate—colon cancer	0.00213	0.00213	CcSEcCtD
Deferiprone—Arthralgia—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Deferiprone—Pharyngitis—Methotrexate—colon cancer	0.00211	0.00211	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Deferiprone—Urinary tract disorder—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Deferiprone—Discomfort—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Deferiprone—Urethral disorder—Methotrexate—colon cancer	0.00209	0.00209	CcSEcCtD
Deferiprone—Diarrhoea—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Deferiprone—Pruritus—Fluorouracil—colon cancer	0.00206	0.00206	CcSEcCtD
Deferiprone—Infection—Capecitabine—colon cancer	0.00202	0.00202	CcSEcCtD
Deferiprone—Nervous system disorder—Capecitabine—colon cancer	0.00199	0.00199	CcSEcCtD
Deferiprone—Eye disorder—Methotrexate—colon cancer	0.00199	0.00199	CcSEcCtD
Deferiprone—Diarrhoea—Fluorouracil—colon cancer	0.00199	0.00199	CcSEcCtD
Deferiprone—Vomiting—Vincristine—colon cancer	0.00198	0.00198	CcSEcCtD
Deferiprone—Cardiac disorder—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Deferiprone—Skin disorder—Capecitabine—colon cancer	0.00197	0.00197	CcSEcCtD
Deferiprone—Rash—Vincristine—colon cancer	0.00197	0.00197	CcSEcCtD
Deferiprone—Hyperhidrosis—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Deferiprone—Dermatitis—Vincristine—colon cancer	0.00196	0.00196	CcSEcCtD
Deferiprone—Headache—Vincristine—colon cancer	0.00195	0.00195	CcSEcCtD
Deferiprone—Angiopathy—Methotrexate—colon cancer	0.00193	0.00193	CcSEcCtD
Deferiprone—Vomiting—Irinotecan—colon cancer	0.00193	0.00193	CcSEcCtD
Deferiprone—Immune system disorder—Methotrexate—colon cancer	0.00192	0.00192	CcSEcCtD
Deferiprone—Mediastinal disorder—Methotrexate—colon cancer	0.00192	0.00192	CcSEcCtD
Deferiprone—Rash—Irinotecan—colon cancer	0.00191	0.00191	CcSEcCtD
Deferiprone—Dermatitis—Irinotecan—colon cancer	0.00191	0.00191	CcSEcCtD
Deferiprone—Chills—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Deferiprone—Headache—Irinotecan—colon cancer	0.0019	0.0019	CcSEcCtD
Deferiprone—Hypotension—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Deferiprone—Mental disorder—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Deferiprone—Malnutrition—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Deferiprone—Nausea—Vincristine—colon cancer	0.00185	0.00185	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Deferiprone—Vomiting—Fluorouracil—colon cancer	0.00185	0.00185	CcSEcCtD
Deferiprone—Rash—Fluorouracil—colon cancer	0.00183	0.00183	CcSEcCtD
Deferiprone—Dermatitis—Fluorouracil—colon cancer	0.00183	0.00183	CcSEcCtD
Deferiprone—Headache—Fluorouracil—colon cancer	0.00182	0.00182	CcSEcCtD
Deferiprone—Nausea—Irinotecan—colon cancer	0.0018	0.0018	CcSEcCtD
Deferiprone—Back pain—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Deferiprone—Dyspepsia—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Deferiprone—Decreased appetite—Capecitabine—colon cancer	0.00177	0.00177	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Deferiprone—Fatigue—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Deferiprone—Pain—Capecitabine—colon cancer	0.00174	0.00174	CcSEcCtD
Deferiprone—Nausea—Fluorouracil—colon cancer	0.00173	0.00173	CcSEcCtD
Deferiprone—Gastrointestinal pain—Capecitabine—colon cancer	0.00166	0.00166	CcSEcCtD
Deferiprone—Urticaria—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Abdominal pain—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Body temperature increased—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Convulsion—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Deferiprone—Arthralgia—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Deferiprone—Discomfort—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Deferiprone—Anaphylactic shock—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Deferiprone—Infection—Methotrexate—colon cancer	0.0015	0.0015	CcSEcCtD
Deferiprone—Hypersensitivity—Capecitabine—colon cancer	0.0015	0.0015	CcSEcCtD
Deferiprone—Nervous system disorder—Methotrexate—colon cancer	0.00148	0.00148	CcSEcCtD
Deferiprone—Skin disorder—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Deferiprone—Hyperhidrosis—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Deferiprone—Asthenia—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Deferiprone—Pruritus—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Deferiprone—Hypotension—Methotrexate—colon cancer	0.00141	0.00141	CcSEcCtD
Deferiprone—Diarrhoea—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00138	0.00138	CcSEcCtD
Deferiprone—Somnolence—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Deferiprone—Dyspepsia—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Deferiprone—Decreased appetite—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Methotrexate—colon cancer	0.00131	0.00131	CcSEcCtD
Deferiprone—Fatigue—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Deferiprone—Pain—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Deferiprone—Vomiting—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Deferiprone—Rash—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Deferiprone—Dermatitis—Capecitabine—colon cancer	0.00128	0.00128	CcSEcCtD
Deferiprone—Headache—Capecitabine—colon cancer	0.00127	0.00127	CcSEcCtD
Deferiprone—Gastrointestinal pain—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Deferiprone—Nausea—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Deferiprone—Urticaria—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Body temperature increased—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Abdominal pain—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Deferiprone—Hypersensitivity—Methotrexate—colon cancer	0.00111	0.00111	CcSEcCtD
Deferiprone—Asthenia—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Deferiprone—Pruritus—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Deferiprone—Diarrhoea—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Deferiprone—Vomiting—Methotrexate—colon cancer	0.000962	0.000962	CcSEcCtD
Deferiprone—Rash—Methotrexate—colon cancer	0.000954	0.000954	CcSEcCtD
Deferiprone—Dermatitis—Methotrexate—colon cancer	0.000953	0.000953	CcSEcCtD
Deferiprone—Headache—Methotrexate—colon cancer	0.000948	0.000948	CcSEcCtD
Deferiprone—Nausea—Methotrexate—colon cancer	0.000899	0.000899	CcSEcCtD
